293 related articles for article (PubMed ID: 2793247)
1. Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines.
Ewing TM; Murphy LJ; Ng ML; Pang GY; Lee CS; Watts CK; Sutherland RL
Int J Cancer; 1989 Oct; 44(4):744-52. PubMed ID: 2793247
[TBL] [Abstract][Full Text] [Related]
2. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.
Murphy LJ; Sutherland RL; Stead B; Murphy LC; Lazarus L
Cancer Res; 1986 Feb; 46(2):728-34. PubMed ID: 3000583
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
4. Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells.
Murphy LJ; Sutherland RL; Lazarus L
Biochem Biophys Res Commun; 1985 Sep; 131(2):767-73. PubMed ID: 2996526
[TBL] [Abstract][Full Text] [Related]
5. The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor.
van den Berg HW; Lynch M; Martin JH
Eur J Cancer; 1993; 29A(12):1771-5. PubMed ID: 8398308
[TBL] [Abstract][Full Text] [Related]
6. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
Koga M; Eisman JA; Sutherland RL
Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins.
Murphy LC; Murphy LJ; Dubik D; Bell GI; Shiu RP
Cancer Res; 1988 Aug; 48(16):4555-60. PubMed ID: 3260816
[TBL] [Abstract][Full Text] [Related]
8. Modulation of lactogenic receptors by progestins in cultured human breast cancer cells.
Murphy LJ; Murphy LC; Stead B; Sutherland RL; Lazarus L
J Clin Endocrinol Metab; 1986 Feb; 62(2):280-7. PubMed ID: 3001123
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of retinoic acid receptors in human breast cancer cells.
Roman SD; Clarke CL; Hall RE; Alexander IE; Sutherland RL
Cancer Res; 1992 Apr; 52(8):2236-42. PubMed ID: 1313739
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1989 Jan; 49(1):112-6. PubMed ID: 2642286
[TBL] [Abstract][Full Text] [Related]
11. Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1991; 17(3):197-210. PubMed ID: 1645605
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
[TBL] [Abstract][Full Text] [Related]
13. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
[TBL] [Abstract][Full Text] [Related]
15. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
Horwitz KB
Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
[TBL] [Abstract][Full Text] [Related]
16. Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens.
Murphy LC; Dotzlaw H
Cancer Res; 1989 Feb; 49(3):599-604. PubMed ID: 2783382
[TBL] [Abstract][Full Text] [Related]
17. Progestin regulation of EGF-receptor mRNA accumulation in T-47D human breast cancer cells.
Murphy LC; Murphy LJ; Shiu RP
Biochem Biophys Res Commun; 1988 Jan; 150(1):192-6. PubMed ID: 2962582
[TBL] [Abstract][Full Text] [Related]
18. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
19. RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor.
Bardon S; Vignon F; Chalbos D; Rochefort H
J Clin Endocrinol Metab; 1985 Apr; 60(4):692-7. PubMed ID: 3972969
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
Hyder SM; Chiappetta C; Stancel GM
Int J Cancer; 2001 May; 92(4):469-73. PubMed ID: 11304678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
